Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theo de Witte

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Blood Reviews|December 17, 2008
The role of iron in patients after bone marrow transplantationTheo de Witte
Clinical Lymphoma, Myeloma & Leukemia|November 1, 2011
Allogeneic stem cell transplantation for myelodysplastic syndromes: critical for cure?Theo de Witte
Leukemia Research|December 5, 2003
Monitoring treatment efficiency in MDS at the molecular level; possibilities now and in the futureJeroen P van Dijk, Theo de Witte
Blood Reviews|July 11, 2006
Autologous and allogeneic stem cell transplantation for myelodysplastic syndromeTheo de Witte, Margriet Oosterveld, Petra Muus
Haematologica|November 4, 2006
Treatment decision-making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: problems and approachesBarbara Deschler, Theo de Witte, Roland Mertelsmann, et al.
Reviews in Clinical and Experimental Hematology|June 13, 2002
Stem cell transplantation for leukemias following myelodysplastic syndromes or secondary to cytotoxic therapyTheo de Witte, Margriet Oosterveld, Bart Span, et al.
Critical Reviews in Oncology/Hematology|January 26, 2016
New insights into transfusion-related iron toxicity: Implications for the oncologistJohn B Porter, Theo de Witte, M Domenica Cappellini, et al.
Seminars in Hematology|October 27, 2007
Autologous stem cell transplantation in myelodysplastic syndromesTheo de Witte, Stefan Suciu, Ronald Brand, et al.
International Journal of Epidemiology|January 19, 2012
Competing risks in epidemiology: possibilities and pitfallsPer Kragh Andersen, Ronald B Geskus, Theo de Witte, et al.
Leukemia Research|April 29, 2021
A phase I clinical trial to study the safety of treatment with tipifarnib combined with bortezomib in patients with advanced stages of myelodysplastic syndrome and oligoblastic acute myeloid leukemiaPetra Muus, Saskia Langemeijer, Sandra van Bijnen, et al.
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Blood Reviews|December 17, 2008
The role of iron in patients after bone marrow transplantationTheo de Witte
Clinical Lymphoma, Myeloma & Leukemia|November 1, 2011
Allogeneic stem cell transplantation for myelodysplastic syndromes: critical for cure?Theo de Witte
Leukemia Research|December 5, 2003
Monitoring treatment efficiency in MDS at the molecular level; possibilities now and in the futureJeroen P van Dijk, Theo de Witte
Blood Reviews|July 11, 2006
Autologous and allogeneic stem cell transplantation for myelodysplastic syndromeTheo de Witte, Margriet Oosterveld, Petra Muus
Haematologica|November 4, 2006
Treatment decision-making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: problems and approachesBarbara Deschler, Theo de Witte, Roland Mertelsmann, et al.
Reviews in Clinical and Experimental Hematology|June 13, 2002
Stem cell transplantation for leukemias following myelodysplastic syndromes or secondary to cytotoxic therapyTheo de Witte, Margriet Oosterveld, Bart Span, et al.
Critical Reviews in Oncology/Hematology|January 26, 2016
New insights into transfusion-related iron toxicity: Implications for the oncologistJohn B Porter, Theo de Witte, M Domenica Cappellini, et al.
Seminars in Hematology|October 27, 2007
Autologous stem cell transplantation in myelodysplastic syndromesTheo de Witte, Stefan Suciu, Ronald Brand, et al.
International Journal of Epidemiology|January 19, 2012
Competing risks in epidemiology: possibilities and pitfallsPer Kragh Andersen, Ronald B Geskus, Theo de Witte, et al.
Leukemia Research|April 29, 2021
A phase I clinical trial to study the safety of treatment with tipifarnib combined with bortezomib in patients with advanced stages of myelodysplastic syndrome and oligoblastic acute myeloid leukemiaPetra Muus, Saskia Langemeijer, Sandra van Bijnen, et al.
Pageof 16